UBS cuts Pacific Biosciences of California target price to $2.70 from $3.05
PACB•UBS cut its target price for Pacific Biosciences of California to $2.70 from $3.05.
Related News
Vireo Growth completes acquisition of FLUENT
VREOF•
Super League Enterprise buys 16 Bitcoin for treasury asset exploration
SLE•
Alarum Technologies announces annual shareholder meeting
ALAR•
Pliant Therapeutics links early immune biomarker activation to clinical response in PLN-101095 trial
PLRX•
Oil slides as Trump signals restraint on Iran despite fresh shipping attacks
USO•